Apabetalone

Overview

Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.

Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.

No indication information available.

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor
A Study of Apabetalone in Subjects With Long -COVID	2024/09/19	NCT06590324	Phase 2	Recruiting	Resverlogix Corp
Apabetalone for Pulmonary Arterial Hypertension	2021/06/07	NCT04915300	Phase 2	Not yet recruiting	Laval University
An Open-Label Study of Apabetalone in Covid Infection	2021/05/20	NCT04894266	Phase 2	Terminated	Resverlogix Corp
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study	2018/08/31	NCT03655704	Early Phase 1	Completed	Steeve Provencher
Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease	2017/07/25	NCT03228940	Phase 1	Withdrawn	Resverlogix Corp
A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis	2017/05/19	NCT03160430	Phase 1	Not yet recruiting	Resverlogix Corp
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD	2015/10/26	NCT02586155	Phase 3	Completed	Resverlogix Corp
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia	2013/05/27	NCT01863225	Phase 2	Terminated	Resverlogix Corp
The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes	2012/11/19	NCT01728467	Phase 2	Completed	Resverlogix Corp
The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation	2011/08/25	NCT01423188	Phase 2	Completed	Resverlogix Corp

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.